Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bioresorbable stent
MedTech
Abbott posts positive, longer-term data for its Esprit BTK stent
In patients with chronic limb-threatening ischemia, the drug-eluting scaffold cut the number of repeat procedures by about half in two years.
Conor Hale
Nov 5, 2024 11:00am
R3 Vascular raises $87M for bioresorbable, below-the-knee stent
May 17, 2024 12:31pm
FDA approves Abbott dissolving stent for arteries below the knee
Apr 29, 2024 9:54am
Reva returns with $45M to bring its dissolving stent to the US
Aug 10, 2022 11:46am
Lyra Therapeutics wants a $58M IPO
Mar 9, 2020 8:25am
Reva expands bioresorbable stent footprint in Europe
Jan 8, 2019 11:34am
